Stocks to Eyes On: Northstar Realty Finance Corp., Arena Pharmaceuticals, Abbott Laboratories, ARMOUR Residential REIT

Lakeway, TX -- (SBWIRE) -- 03/16/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Northstar Realty Finance Corp. (NYSE:NRF) shares decreased 1.04% to $9.56. The company, on Feb. 20, announced that it has priced an underwritten public offering of 30,000,000 shares of common stock at a public offering price of $8.39 per share. The Company has granted the underwriters a 30-day option to purchase up to 4,500,000 additional shares of common stock. The offering is expected to close on February 25, 2013. Deutsche Bank Securities and UBS Investment Bank are acting as the joint book-running managers of the offering. The Company intends to use the net proceeds of the offering to make investments relating to its business, to repurchase or pay its liabilities and for general corporate purposes.

How Should Investors Trade NRF The Recent Movement? Find Out Here

Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) shares dropped 0.99% to $8.03. The company, on Mar. 4, said it lost $21.3 million in the fourth quarter, compared to $23.7 million of 2011. Total interest and other expense in the fourth quarter of 2012 decreased to $1.0 million, compared to $5.4 million in the fourth quarter of 2011. Total interest and other expense in the full year ended December 31, 2012, increased to $28.4 million, compared to $26.4 million in full year ended December 31, 2011.

Is ARNA Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Abbott Laboratories(NYSE:ABT) shares declined 2.08% to $34.41 after ABT‘s stock had its “hold” rating restated by analysts at TheStreet in a research report issued to clients and investors on Mar. 14.

Additionally, the company, on Mar. 11, announced positive long-term results for the company's innovative Absorb™ Bioresorbable Vascular Scaffold (BVS). Three-year results from 101 patients in the second stage of the ABSORB trial were presented at the 62nd Annual Scientific Session of the American College of Cardiology (ACC) in San Francisco.

Is ABT a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

ARMOUR Residential REIT, Inc.(NYSE:ARR) shares gained 0.32% to $6.29. The company, on Mar. 13, announced a second quarter 2013 monthly cash dividend rate for the Company's Common Stock of $0.07 per share. The Company also confirmed the Q2 2013 monthly cash dividends for the Company's Series A and Series B Preferred Stock.

How Should Investors Trade ARR After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.